C-reactive Protein Apheresis: A Novel Treatment Approach in Acute Necrotising Pancreatitis
Felix Götzinger1, Michael Kunz2, Felix Mahfoud3
1Department of Cardiology and Cardiovascular Research Institute Basel, University Heart Center Basel, University Hospital Basel, Switzerland. felix.goetzinger@usb.ch.
Abstract:
Acute necrotizing pancreatitis is a severe condition associating with high morbidity and mortality. In most cases, supportive therapy is the only available therapeutic option. Herein, we report a case of a 29-year-old male who presented with severe acute necrotizing pancreatitis caused by hypertriglyceridemia, who consequently developed acute respiratory distress syndrome and multi-organ failure. We used an off-label C-reactive protein apheresis to target the sterile inflammatory reactions additional to optimal supportive therapy with invasive ventilation, prone positioning, continuous veno-venous hemodialysis using a CytoSorb™ particle filter, antibiotics, vasopressors, and fluids. After 18 days of intensive care treatment and 11 days of normal care treatment, the patient could be discharged alive.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Kidney Injury V: Interprofessional Care

